Show simple item record

dc.contributor.authorMeng, Xiangdong
dc.contributor.authorNoyes, Marcus Blaine
dc.contributor.authorZhu, Lihua Julie
dc.contributor.authorLawson, Nathan D.
dc.contributor.authorWolfe, Scot A.
dc.date2022-08-11T08:08:51.000
dc.date.accessioned2022-08-23T16:09:50Z
dc.date.available2022-08-23T16:09:50Z
dc.date.issued2008-05-27
dc.date.submitted2009-02-19
dc.identifier.citationNat Biotechnol. 2008 Jun;26(6):695-701. Epub 2008 May 25. <a href="http://dx.doi.org/10.1038/nbt1398">Link to article on publisher's site</a>
dc.identifier.issn1546-1696 (Electronic)
dc.identifier.doi10.1038/nbt1398
dc.identifier.pmid18500337
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32793
dc.description.abstractDirect genomic manipulation at a specific locus is still not feasible in most vertebrate model organisms. In vertebrate cell lines, genomic lesions at a specific site have been introduced using zinc-finger nucleases (ZFNs). Here we adapt this technology to create targeted mutations in the zebrafish germ line. ZFNs were engineered that recognize sequences in the zebrafish ortholog of the vascular endothelial growth factor-2 receptor, kdr (also known as kdra). Co-injection of mRNAs encoding these ZFNs into one-cell-stage zebrafish embryos led to mutagenic lesions at the target site that were transmitted through the germ line with high frequency. The use of engineered ZFNs to introduce heritable mutations into a genome obviates the need for embryonic stem cell lines and should be applicable to most animal species for which early-stage embryos are easily accessible.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18500337&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1038/nbt1398
dc.subjectAnimals; Animals, Genetically Modified; Deoxyribonucleases; *Gene Silencing; Gene Targeting; Genetic Engineering; Mutagenesis, Site-Directed; Protein Engineering; Zebrafish; Zebrafish Proteins; Zinc Fingers
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleTargeted gene inactivation in zebrafish using engineered zinc-finger nucleases
dc.typeJournal Article
dc.source.journaltitleNature biotechnology
dc.source.volume26
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/1346
dc.identifier.contextkey727541
html.description.abstract<p>Direct genomic manipulation at a specific locus is still not feasible in most vertebrate model organisms. In vertebrate cell lines, genomic lesions at a specific site have been introduced using zinc-finger nucleases (ZFNs). Here we adapt this technology to create targeted mutations in the zebrafish germ line. ZFNs were engineered that recognize sequences in the zebrafish ortholog of the vascular endothelial growth factor-2 receptor, kdr (also known as kdra). Co-injection of mRNAs encoding these ZFNs into one-cell-stage zebrafish embryos led to mutagenic lesions at the target site that were transmitted through the germ line with high frequency. The use of engineered ZFNs to introduce heritable mutations into a genome obviates the need for embryonic stem cell lines and should be applicable to most animal species for which early-stage embryos are easily accessible.</p>
dc.identifier.submissionpathgsbs_sp/1346
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.contributor.departmentProgram in Gene Function and Expression
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages695-701


This item appears in the following Collection(s)

Show simple item record